Quarterly Results

ZIM LABORATORIES LTD.

NSE : ZIMLABBSE : 541400ISIN CODE : INE518E01015Industry : Pharmaceuticals & DrugsHouse : MNC
BSE95.500.1 (+0.1 %)
PREV CLOSE ( ) 95.40
OPEN PRICE ( ) 96.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 22858
TODAY'S LOW / HIGH ( )94.50 97.50
52 WK LOW / HIGH ( )67.45 151.75
NSE94.95-0.55 (-0.58 %)
PREV CLOSE( ) 95.50
OPEN PRICE ( ) 95.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 94.95 (1943)
VOLUME 169532
TODAY'S LOW / HIGH( ) 94.10 97.45
52 WK LOW / HIGH ( )68.05 152.7
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
Audited
UnAudited
Audited
Net Sales
962.93
858.26
674.43
1054.11
Total Expenditure
847.59
765.02
626.13
899.6
PBIDT (Excl OI)
115.34
93.24
48.3
154.51
Other Income
11.12
14.22
11.15
6.94
Operating Profit
126.46
107.46
59.45
161.45
Interest
16.96
12.17
17.34
12.7
Exceptional Items
NA
NA
NA
NA
PBDT
109.5
95.29
42.11
148.75
Depreciation
39.35
40.86
40.26
49.3
Profit Before Tax
70.14
54.43
1.85
99.44
Tax
22.29
12.94
-0.41
27.08
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
47.85
41.49
2.26
72.36
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
47.85
41.49
2.26
72.36
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
47.85
41.5
2.27
72.36
Equity Capital
487.26
487.26
487.26
487.26
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
0.98
0.85
0.04
1.48
Calculated EPS (Annualised)
3.92
3.40
0.18
5.94
No of Public Share Holdings
32517834
32517834
32517834
32517834
% of Public Share Holdings
66.74
66.74
66.74
66.74
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
11.97
10.86
7.16
14.65
PBIDTM%
13.13
12.52
8.81
15.31
PBDTM%
11.37
11.10
6.24
14.11
PBTM%
7.28
6.34
0.27
9.43
PATM%
4.97
4.83
0.33
6.86
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.